SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-040487
Filing Date
2019-11-05
Accepted
2019-11-05 17:16:41
Documents
68
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 Q3 2019 10-Q gthx-10q_20190930.htm   iXBRL 10-Q 1922975
2 EX-31.1 gthx-ex311_6.htm EX-31.1 17940
3 EX-31.2 gthx-ex312_8.htm EX-31.2 18548
4 EX-32.1 gthx-ex321_7.htm EX-32.1 7314
5 EX-32.2 gthx-ex322_9.htm EX-32.2 7309
6 GRAPHIC g2gscos5iqus000003.jpg GRAPHIC 1219
7 GRAPHIC g2gscos5iqus000002.jpg GRAPHIC 1219
8 GRAPHIC g2gscos5iqus000001.jpg GRAPHIC 1211
  Complete submission text file 0001564590-19-040487.txt   6940664

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION SCHEMA gthx-20190930.xsd EX-101.SCH 44611
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE gthx-20190930_cal.xml EX-101.CAL 40411
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE gthx-20190930_def.xml EX-101.DEF 121436
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE gthx-20190930_lab.xml EX-101.LAB 337699
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE gthx-20190930_pre.xml EX-101.PRE 257567
25 EXTRACTED XBRL INSTANCE DOCUMENT gthx-10q_20190930_htm.xml XML 1442979
Mailing Address P. O. BOX # 110341 RESEARCH TRIANGLE PARK NC 27709
Business Address 79 T.W. ALEXANDER DRIVE 4501 RESEARCH COMMONS, SUITE 100 RESEARCH TRIANGLE PARK NC 27709 919-213-9835
G1 Therapeutics, Inc. (Filer) CIK: 0001560241 (see all company filings)

IRS No.: 263648180 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38096 | Film No.: 191194300
SIC: 2834 Pharmaceutical Preparations